It is the first drug to have an impact on the symptoms of manic depression since the introduction of lithium more than 50 years ago. In international trials over the past two years, daily doses of ...
UK biotech Compass Pathways is planning a $100 million US IPO as it seeks to further develop its depression treatment ... laid out its plans to develop the drug known as COMP360, which is a ...
Almost Three Quarters of Adolescents Experience Depression or Anxiety Dec ... Multiple Sclerosis Drug May Help With Poor Working Memory Nov. 18, 2024 — Fampridine is currently used to improve ...
Shares in Axsome Therapeutics have rocketed on FDA approval of its depression therapy Auvelity ... or selective serotonin reuptake inhibitor drugs can take weeks to elevate mood, placing severely ...
Tryngolza (olezarsen) has been approved by the U.S. Food and Drug Administration as an adjunct to diet to reduce triglycerides in adults with familial chylomicronemia syndrome (FCS), which can ...
Depression refers to a state of low mood that can be accompanied with loss of interest in activities that the individual normally perceived as pleasurable, altered appetite and sleep/wake balance ...
In June 2024, Health Canada committed to publishing a list of drugs that are critical to patients and vulnerable to shortages. The list will help drug shortage stakeholders focus their actions and ...
Healthline News reports on emerging research, new treatments, diet, exercise, and trending topics in health and wellness. All articles are written by our network of editors and contributors ...
As we bring in 2025, CBC News spoke with Rebecca Rackow from the Canadian Mental Health Association – Saskatchewan about the best ways to achieve mental health resolutions manageably and incrementally ...